@FiercePharma: Lundbeck's refusal to sell pentobarbital to prisons hits Ohio's execution plans. More from Reuters | Follow @FiercePharma
@EricPFierce: FDA warning letter for Strides Arcolab Agila Speciaities plant arrives. Mylan not too concerned. Story from FiercePharmaManufacturing | Follow @EricPFierce
> Forest Laboratories ($FRX) sued several generics makers for patent infringement over their plans to knock off the fibromyalgia drug Savella. Release
> The U.K.'s National Health Service adopted Roche's ($RHHBY) new injectable form of the HER2-positive breast cancer drug Herceptin. Report
> Par Pharmaceutical started shipping the new antidepressant Khedezla ER, a copycat version of Pfizer's ($PFE) Pristiq that isn't generically substitutable for the brand. Report
> Purdue Pharma won FDA approval for a new dosage strength of its Butrans Transdermal painkiller patch. Report
@FierceMedDev: Biocept Laboratories becomes latest Dx outfit to explore IPO. ICYMI yesterday | Follow @FierceMedDev
@MarkHFierce: Medtronic won expanded indications for one of its key vascular stents. Release | Article | Follow @MarkHFierce
> Stryker inks $1.7B deal for Mako. News
> Tool to predict bad implant reactions shows potential. Item
> EnteroMedics slides after FDA squints at obesity device. Article
Biotech News
@FierceBiotech: The 2013 Fierce 15 biotech execs take a bow. Editor's corner | FierceBiotech's 2013 Fierce 15 | Follow @FierceBiotech
@JohnCFierce: Merck KGaA doubles down on Oncothyreon's failed cancer vaccine. Report | Follow @JohnCFierce
@DamianFierce: Apparently no one wanted to spend ~$3B on Clovis Oncology. Perhaps Big Pharma wants its biotechs to generate revenue. Story | Follow @DamianFierce
@EmilyMFierce: Stem cell reprogramming made easier by removing one protein. Popular yesterday from FierceBiotech Research | Follow @EmilyMFierce
> Infinity dumps lung cancer drug after PhII trial fails survival test. Article
> Plotting Asia expansion, Amgen blueprints plans for Shanghai research center. More
> Ophthotech, Foundation Medicine loot booming biotech IPO market for $273M. Article
Drug Delivery News
@MichaelGFierce: Laser-sensitive surface enables IV-drug identification for safer delivery. Story | Follow @MichaelGFierce
> Study: Artificial pancreas with inhaled insulin improves glucose control. More
> Alnylam heralds positive results for RNAi amyloidosis drug. Article
> Surefire collects $16.4M to expand cancer-drug catheter biz. Item
> Bind collects $70.5M IPO to support Accurin tech. Story
Diagnostics News
> Cognoptix Alzheimer's eye test generates robust trial results. Article
> Alzheimer's diagnosis may gain from PET imaging of tau proteins. Report
> Case Western, GSK find promise with MS diagnostic 'probe.' Story
> In vitro Dx to remain at top of med tech heap. More
> Cigna: Genetic counseling mandates will come for other Dx tests. Article
And Finally... The new federal health law is expected to cause a surge in patients seeking mental healtlh treatment. Report